TD Waterhouse Canada’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

TD Waterhouse Canada’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$824K	Buy	5,265 +4,436	+535%	+$600K	﹤0.01%	750
2026 Q1	$106K	Sell	829 -6,513	-89%	-$813K	﹤0.01%	1182
2025 Q4	$895K	Buy	7,342 +6,687	+1,021%	+$767K	0.01%	594
2025 Q3	$66.5K	Hold	655	–	–	﹤0.01%	1127
2025 Q2	$54.4K	Sell	655 -961	-59%	-$76.7K	﹤0.01%	1102
2025 Q1	$126K	Sell	1,616 -1,067	-40%	-$95.4K	﹤0.01%	886
2024 Q4	$242K	Buy	2,683 +92	+4%	+$8.91K	﹤0.01%	761
2024 Q3	$253K	Buy	2,591 +2,122	+452%	+$208K	﹤0.01%	738
2024 Q2	$43.7K	Buy	469 +190	+68%	+$17K	﹤0.01%	1050
2024 Q1	$32.6K	Sell	279 -539	-66%	-$50K	﹤0.01%	1150
2023 Q4	$80K	Sell	818 -22	-3%	-$1.63K	﹤0.01%	847
2023 Q3	$65.4K	Sell	840 -201	-19%	-$16.1K	﹤0.01%	862
2023 Q2	$98K	Sell	1,041 -1,298	-55%	-$109K	﹤0.01%	792
2023 Q1	$207K	Buy	2,339 +203	+10%	+$16.8K	﹤0.01%	649
2022 Q4	$206K	Buy	2,136 +599	+39%	+$48.5K	﹤0.01%	642
2022 Q3	$148K	Sell	1,537 -38,163	-96%	-$3.22M	﹤0.01%	709
2022 Q2	$3.24M	Sell	39,700 -505	-1%	-$37.9K	0.04%	247
2022 Q1	$4.7M	Buy	40,205 +13,607	+51%	+$1.26M	0.05%	219
2021 Q4	$3.76M	Buy	+26,598	New	+$3.21M	0.04%	257

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

TD Waterhouse Canada's XBI Position: Q2 2026 in Review

TD Waterhouse Canada increased its State Street SPDR S&P Biotech ETF (XBI) stake by 535% in Q2 2026, buying an estimated $600K and bringing the position to 5,265 shares worth $824K. The position accounts for ﹤0.01% of the portfolio, ranked #750.

TD Waterhouse Canada first reported a position in XBI in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.7M in Q1 2022. 936 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

TD Waterhouse Canada held 5,265 shares of State Street SPDR S&P Biotech ETF worth $824K as of Q2 2026.
TD Waterhouse Canada bought 4,436 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $600K.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #750 holding.
TD Waterhouse Canada first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 19 quarters since.
TD Waterhouse Canada's State Street SPDR S&P Biotech ETF position peaked at $4.7M in Q1 2022.
936 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.